| Financial Year |
March 31 2023 |
| Monetary Funds |
175,492,514.38 |
| Held-for-trading Financial Assets |
43,235,681.31 |
| Notes Receivable |
-- |
| Accounts Receivable |
38,346,788.61 |
| Advances to Suppliers |
8,861,537.60 |
| Other Receivables |
4,050,149.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
153,489,470.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,640,582.74 |
| Total Current Assets |
427,116,724.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
31,706,182.16 |
| Fixed Assetes |
423,903,245.98 |
| Under-construction Projects |
5,613,017.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,133,218.17 |
| R&D expenses |
-- |
| Goodwill |
7,151,751.68 |
| Long-Term Deferred and Prepaid Expenses |
4,938,197.04 |
| Deferred Income Tax Assets |
778,888.51 |
| Other Non-Current Assets |
1,904,905.66 |
| Sub-Total of Non-Current Assets |
556,277,280.45 |
| Total Assets |
983,394,005.35 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
28,774,080.04 |
| Accounts Payable |
167,076,511.36 |
| Accounts Received In Advance |
342,507.65 |
| Employee Compensation Payable |
14,367,253.19 |
| Taxes Payable |
8,142,975.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,747,524.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,636,547.04 |
| Other Current Liabilities |
1,607,473.51 |
| Sub-Total of Current Liabilities |
268,863,708.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
315,425.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,180,492.01 |
| Total Liabilities |
277,044,200.87 |
| Paid-In Capital(Or Share Stock) |
156,000,000.00 |
| Capital Surplus |
314,769,606.73 |
| Surplus Reserve |
30,677,336.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
193,059,053.70 |
| Minority Stockholder's Interest |
11,843,807.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
694,505,996.97 |
| Owner's Equity（Stockholder's Equity） |
706,349,804.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
983,394,005.35 |
